THE ASSOCIATION OF VASCULAR DYSFUNCTION AND PLATELET REACTIVITY IS REGULATED BY THE INTERACTION BETWEEN ANTIDIABETIC AND ANTIPLATELET TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUSGerasimos Siasos, Dimitris Tousoulis, Panagiota K. Stampouloglou et al.|Journal of the American College of Cardiology|2019Cited by 0
TREATMENT OPTIMIZATION WITH SODIUM/GLUCOSE COTRANSPORTER-2 INHIBITORS, DIPEPTIDYL PEPTIDASE-4 INHIBITORS OR GLYCAGONE LIKE PEPTIDE-1 IMPROVES VASCULAR DYSFUNCTION AND ACHIEVES BETTER GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUSGerasimos Siasos, Dimitris Tousoulis, Evanthia Bletsa et al.|Journal of the American College of Cardiology|2019Cited by 0
Effects of novel antidiabetic agents on the arterial wall elastic properties as a marker of vascular function in patients with type 2 diabetes mellitusPanagiota K. Stampouloglou, Dimitris Tousoulis, Evangelos Oikonomou et al.|Endocrine Abstracts|2019Cited by 0